Optima-Farmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-03-31
Share capital
50,000.00 PLN
Registered address
ul. Krakowska 4, 63-510 Mikstat, Poland
Electronic delivery address
AE:PL-73464-32734-GVIGT-18

Financials

Revenue history (in k)

Financial insight

  • Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.

Filing timeliness

Financial statements were filed on time, on average 38 days early.

  • 202518/06/2026
  • 202411/06/2025
  • 202322/06/2024
  • 202227/06/2023
  • 202130/06/2022
  • 202029/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.05mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 63.93kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 2.96mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.04mMedianUSD 544.32kAverageUSD 1.76m

Industry

National Health Fund (NFZ) contracts

Optima-Farma has been an NFZ healthcare provider since 2024. In 2026 it is performing 3 contracts with a total value of USD 567.27. All its contracts were worth USD 981.55 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeswielkopolskie2USD 567.27
Other services provided in pharmacieswielkopolskie1USD 0.00

Trademarks

Optima-Farma holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2017.

MarkNumberClassesStatusProtected until
AptimO.pl dla zdrowiaZ.46838135Protected Mar 3, 2027
neopharmaZ.46839435Protected Mar 3, 2027
dobreziółka.plZ.46837735Refused –
MarkProtected until
AptimO.pl dla zdrowiaMar 3, 2027
neopharmaMar 3, 2027
dobreziółka.pl–

Authorized Representatives

Daria Lichota – President of the Management Board
Marian Teodor Inerowicz – Vice President of the Management Board
Joanna Maria Iwańska – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorized independently to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Maria Irena Inerowiczage 70
500$6,753.1150%
Marian Teodor Inerowiczage 73
500$6,753.1150%

Maria Irena Inerowicz and Marian Teodor Inerowicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-04-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$25,113
Buildings and premises
$13,559

Public aid

87 public aid cases recorded, with a total value of $102,337.

PurposeGross amount
Aid in the form of wage subsidies for employing workers with disabilities
$419
Aid in the form of wage subsidies for employing workers with disabilities
$419
Aid in the form of wage subsidies for employing workers with disabilities
$419

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Rutkiewicz I Wspólnicysp. j.

FAQ

Last updated: 2026-06-19